Nectero Medical Inc

Tempe, AZ · Founded 2017 · Medtech · Private

Vascular intervention medical devices for treating vascular diseases

Claim this profile

Follows are private to you and power your alerts

Updated · necterotherapeutics.com

Sector
Medtech
Headquarters
Tempe, AZ
Founded
2017
Latest Form D
$32.8M, May 2024
Total capital
$51M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$51M
3 Form D · last May 2024
30 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
4
36 pending · first 2018
Rank in peer group#337 of 1112

Capital timeline

20202021202220232024FEDERAL ↑EQUITY ↓Cumulative $52.5M1st Form D$1.5M2nd Form D$18.2M3rd Form D$32.8M
20202021202220232024FEDERAL ↑EQUITY ↓Cumulative $52.5M1st Form D$1.5M2nd Form D$18.2M3rd Form D$32.8M

Latest events

  • Private capital raisedForm D · SEC · 3rd filing$32.8M
  • Private capital raisedForm D · SEC · 2nd filing$18.2M
  • Offering registeredForm D · SEC · 1st filing$1.5M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1112 peers

Line = median

Medtech · Device

  • Granted patents#337 · top 30%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Anil DasuDirectorNamed in SEC Form D filings
  • Bruce RobertsDirectorNamed in SEC Form D filings
  • Bryan ZieglerExecutive OfficerNamed in SEC Form D filings
  • Colin MorrisonDirectorNamed in SEC Form D filings
  • Jack SpringerExecutive Officer, DirectorNamed in SEC Form D filings
  • John SpringerExecutive Officer, DirectorNamed in SEC Form D filings
Show all 7 people
  • Robert WhirleyDirectorNamed in SEC Form D filings

What it has protected

USPTO · 4 granted of 40
  • PendingMethods For Treatment Of Post-surgery Laxity Of Tendons And Tendon RepairUSPTOApplication 19552543
  • PendingPurified pentagalloyl glucose and devices for deliveryUSPTOApplication 19057211
  • GrantedSystems For Aneurysm TreatmentUSPTOUS 12,303,134
Show all 40 patent records
  • Methods For Treatment Of Post-surgery Laxity Of Tendons And Tendon RepairSep 10, 2026 · Application 19552543Pending
  • Purified pentagalloyl glucose and devices for deliverySep 18, 2025 · Application 19057211Pending
  • Systems For Aneurysm TreatmentMay 20, 2025 · US 12,303,134Granted
  • Systems And Methods For Treating An Aortic Tear Or DissectionFeb 13, 2025 · Application 18667538Pending
  • Composition And Methods For Treating An AneurysmNov 28, 2024 · Application 18674433Pending
  • Methods For Aneurysm TreatmentNov 19, 2024 · US 12,144,506Granted
  • Methods For Treatment Of Post-surgery Laxity Of Tendons And Tendon RepairOct 5, 2023 · Application 18177019Pending
  • Purified Pentagalloyl Glucose And Devices For DeliveryMay 17, 2022 · US 11,331,102Granted
  • Methods For Treatment Of Post-surgery Laxity Of Tendons And Tendon RepairJan 6, 2022 · Application 17448450Pending
  • Methods Of Treatment Associated With Endovascular GraftsJan 6, 2022 · Application 17448318Pending
  • Vascular Medical Devices With Sealing Elements And Procedures For The Treatment Of Isolated Vessel SectionsDec 6, 2018 · Application 15889933Pending
  • Compositions For Tissue StabilizationDec 6, 2018 · Application 15952099Pending
  • Devices For The Treatment Of Vascular AneurysmNov 29, 2018 · Application 15963312Pending
  • Coated Balloons For Blood Vessel StabilizationNov 15, 2018 · Application 15947399Pending
  • Vascular Medical Devices With Sealing Elements And Procedures For The Treatment Of Isolated Vessel SectionsFeb 13, 2018 · US 9,889,279Granted
  • Compositions For Tissue StabilizationMay 19, 2016 · Application 15005821Pending
  • Devices For The Treatment Of Vascular AneurysmJan 1, 2015 · Application 14486794Pending
  • Methods And Devices For Treatment Of Peripheral Vascular DiseaseApplication 62824044Pending
  • Methods And Devices For Treatment Of Pelvic Organ ProlapseApplication 62824031Pending
  • Purified Pentagalloyl Glucose And Devices For DeliveryApplication PCTUS2019024142Pending
  • Treatment Of Tumors Using Entagalloyl GlucoseApplication 62824187Pending
  • Treatment Of Congestive Heart Failure Using Pentagalloyl GlucoseApplication 62824034Pending
  • Methods And Devices For Transcatheter Aortic Valve ImplantationApplication 62824160Pending
  • Methods And Devices For Treatment Of Post-surgery Laxity Of Tendons And Tendon RepairApplication 62824020Pending
  • Methods And Devices For Repair Of Peripheral AneurysmsApplication 62824167Pending
  • Methods And Devices For Treatment Of Post-surgery Laxity Of Tendons And Tendon RepairApplication PCTUS2020024731Pending
  • Methods And Devices For Repair Of Neuro AneurysmsApplication 62824100Pending
  • Devices And Methods For Treatment Of Tendon And Soft Tissue Attachment In Surgical RepairApplication 62824058Pending
  • Methods And Devices For Treatments Associated With Endovascular GraftsApplication 62824091Pending
  • Methods And Devices For Treatment Of DissectionsApplication 62824016Pending
  • Methods And Devices For Treatment Of Stress Urinary IncontinenceApplication 62824105Pending
  • Methods And Devices For Mitral Valve Repair Or Replacement ProceduresApplication 62824033Pending
  • Purified Pentagalloyl Glucose And Devices For DeliveryApplication 62714346Pending
  • Methods And Devices For Treatments Associated With Endovascular GraftsApplication PCTUS2020024739Pending
  • Systems And Methods For Treating An Aortic Tear Or DissectionApplication 63283168Pending
  • Systems And Methods For Treating An Aortic Tear Or DissectionApplication PCTUS2022080344Pending
  • Composition And Methods For Treating Elastin-depleted TissuesApplication 63504375Pending
  • Purified Pentagalloyl Glucose And Devices For DeliveryApplication PCTUS2019024140Pending
  • Composition And Methods For Treating An AneurysmApplication 63643692Pending
  • Methods And Devices For Transcatheter Aortic Valve ReplacementApplication 62824119Pending

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .